China Conducts First-ever Centralized Tender For Orthopedic Products
This article was originally published in PharmAsia News
More consolidation is expected in China’s device sector as the country completes its first central tender for orthopedic products.
You may also be interested in...
China’s Simcere Receives Buyout Offer From Its Chairman, But Could Delisting Be A Negative Overseas?
Simcere would join Chinese firms 3SBio and ShangPharma in pulling out of the U.S. stock market.
The Ministry of Health’s GSP regulation tries to plug a hole in supply chain security through tighter IT controls, such as requiring electronic barcodes.
Pfizer Global Security Regional Director Harry Waskiewicz On Busting Counterfeit Drugs: An Interview With PharmAsia News (Part 2 of 2)
Pfizer case studies show counterfeiting now goes far beyond a Viagra problem.